Cargando…

Recombinant Complement Receptor 2 Radiolabeled with [(99m)Tc(CO)(3)](+) : A Potential New Radiopharmaceutical for Imaging Activated Complement

We describe the design and synthesis of a new Tc-99m labeled bioconjugate for imaging activated complement, based on Short Consensus Repeats 1 and 2 of Complement Receptor 2 (CR2), the binding domain for C3d. To avoid non specific modification of CR2 and the potential for modifying lysine residues c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badar, Adam, DeFreitas, Sarah, McDonnell, James M., Yahya, Norhakim, Thakor, David, Razavi, Reza, Smith, Richard, Sacks, Steven, Mullen, Gregory E. D.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071809/ https://www.ncbi.nlm.nih.gov/pubmed/21494666 http://dx.doi.org/10.1371/journal.pone.0018275

Ejemplares similares

Physicochemical and Biological Study of (99m)Tc and (68)Ga Radiolabelled Ciprofloxacin and Evaluation of [(99m)Tc]Tc-CIP as Potential Diagnostic Radiopharmaceutical for Diabetic Foot Syndrome Imaging
por: Koźmiński, Przemysław, et al.
Publicado: (2021)

One-step, kit-based radiopharmaceuticals for molecular SPECT imaging: a versatile diphosphine chelator for (99m)Tc radiolabelling of peptides
por: Hungnes, Ingebjørg N., et al.
Publicado: (2021)

In Vitro Evaluation of Tc-99m Radiopharmaceuticals for Gastric Emptying Studies
por: Ertay, Türkan, et al.
Publicado: (2014)

Influence of Storage Temperature on Radiochemical Purity of (99m)Tc-Radiopharmaceuticals
por: Uccelli, Licia, et al.
Publicado: (2018)

(99m)Tc-Radiolabeled TPGS Nanomicelles Outperform (99m)Tc-Sestamibi as Breast Cancer Imaging Agent
por: Tesan, Fiorella C., et al.
Publicado: (2019)

(99m)Tc-radiolabeled Levofloxacin and micelles as infection and inflammation imaging agents
por: Silindir-Gunay, Mine, et al.
Publicado: (2020)

Comparison of the Absorbed Dose for (99m)Tc-Diethylenetriaminepentaacetic Acid and (99m)Tc-Ethylenedicysteine Radiopharmaceuticals using Medical Internal Radiation Dosimetry
por: Pirdamooie, Shokufeh, et al.
Publicado: (2015)

Mathematical Simulation of Transport Kinetics of Tumor-Imaging Radiopharmaceutical (99m)Tc-MIBI
por: Shevtsova, O. N., et al.
Publicado: (2017)

Alternative chromatographic system for the quality control of lipophilic technetium-99m radiopharmaceuticals such as [(99m)Tc(MIBI)(6)](+)
por: Faria, D.P., et al.
Publicado: (2015)

Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using (99m)Tc-HMPAO
por: Hwang, Do Won, et al.
Publicado: (2015)

(99m)Tc-radiolabeled GE11-modified peptide for ovarian tumor targeting
por: Rahmanian, Najmeh, et al.
Publicado: (2017)

[(99m)Tc]Technetium-Labeled Niosomes: Radiolabeling, Quality Control, and In Vitro Evaluation
por: Ekinci, Meliha, et al.
Publicado: (2023)

Radiolabeling and Biological Evaluation of Novel (99m)Tc-Nitrido and (99m)Tc-Oxo Complexes with 4-Methoxy-(L)-Phenylalanine Dithiocarbamate for Tumor Imaging
por: Yin, Guangxing, et al.
Publicado: (2022)

Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
por: Miller, Edward J., et al.
Publicado: (2022)

Synthesis, Radiolabeling and Biological Evaluation of (99m)Tc-labeled Deoxyglucose Derivatives for Molecular Imaging
por: Sadeghzadeh, Masoud, et al.
Publicado: (2013)

Radiation Levels from Toilets Used By Patients Injected with 99mTc-based Radiopharmaceuticals in Ibadan
por: Ejeh, John Enyi, et al.
Publicado: (2014)

Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of (99m)Tc-Tricarbonyl-Based Radiopharmaceuticals
por: Giammei, Carolina, et al.
Publicado: (2020)

Radiolabeled Somatostatin Analogs—A Continuously Evolving Class of Radiopharmaceuticals
por: Fani, Melpomeni, et al.
Publicado: (2022)

(99m)Tc‐aprotinin – optimisation and validation of radiolabelling kits for routine preparation for diagnostic imaging of amyloidosis
por: Denholt, Charlotte, et al.
Publicado: (2016)

Development of (99m)Tc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer
por: Rainone, Paolo, et al.
Publicado: (2017)

Synthesis and In Vitro Evaluation of Gold Nanoparticles Functionalized with Thiol Ligands for Robust Radiolabeling with (99m)Tc
por: Apostolopoulou, Adamantia, et al.
Publicado: (2021)

Noninvasive Imaging of Activated Complement in Ischemia‐Reperfusion Injury Post–Cardiac Transplant
por: Sharif‐Paghaleh, E., et al.
Publicado: (2015)

Common Shortcomings in Study on Radiopharmaceutical Design Research: A Case Study of (99m)Tc-Labelled Methotrexate
por: Koźmiński, Przemysław, et al.
Publicado: (2021)

Radiolabeled tirofiban – a potential radiopharmaceutical for detection of deep venous thrombosis
por: Darkovska-Serafimovska, Marija, et al.
Publicado: (2016)

Evaluation of a new radiolabeled bombesin derivative with (99m)Tc as potential targeted tumor imaging agent
por: Sadeghzadeh, N., et al.
Publicado: (2013)

(99m)Tc-Radiolabeled Silica Nanocarriers for Targeted Detection and Treatment of HER2-Positive Breast Cancer
por: Rainone, Paolo, et al.
Publicado: (2021)

Radiolabeling and Preliminary Evaluation of (99m)Tc-Labeled DNA Cube Nanoparticles as Potential Tracers for SPECT Imaging
por: Duan, Xiaoyan, et al.
Publicado: (2021)

Tagging Efficiency of (99m) Tc-SC Radiolabeled Alternative Gastric Emptying Meals: A Quantitative Study
por: Pal, Deepak Kumar, et al.
Publicado: (2022)

(99m)Tc Glucarate as a Potential Radiopharmaceutical Agent for Assessment of Tumor Viability: From Bench to the Bed Side
por: Choudhury, Partha S., et al.
Publicado: (2012)

Estimating the Absorbed Dose of Organs in Pediatric Imaging of (99m)Tc-DTPATc-DTPA Radiopharmaceutical using MIRDOSE Software
por: K., Ebrahimnejad Gorji, et al.
Publicado: (2019)

Radiosynthesis, quality control, biodistribution, and infection-imaging study of a new (99m)Tc-labeled ertapenem radiopharmaceutical
por: Naqvi, Syed Ali Raza, et al.
Publicado: (2022)

Complement activation by recombinant adenoviruses
por: Cichon, G, et al.
Publicado: (2002)

Anti-CD20 Immunoglobulin G Radiolabeling with a (99m)Tc-Tricarbonyl Core: In Vitro and In Vivo Evaluations
por: Carpenet, Hélène, et al.
Publicado: (2015)

Hydroxyapatite and Titanium Dioxide Nanoparticles: Radiolabelling and In Vitro Stability of Prospective Theranostic Nanocarriers for (223)Ra and (99m)Tc
por: Suchánková, Petra, et al.
Publicado: (2020)

Radiolabeling and Preliminary Evaluation of (99m)Tc-Labeled DNA Cube Nanoparticles as Potential Tracers for SPECT Imaging [Corrigendum]
Publicado: (2022)

The New Radiolabeled Peptide (99m)TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
por: Gherghe, Mirela, et al.
Publicado: (2022)

(99m)tc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation
por: Beiki, Davood, et al.
Publicado: (2013)

Dose-Dependent Internalization and Externalization Integrity Study of Newly Synthesized (99m)Tc-Thymoquinone Radiopharmaceutical as Cancer Theranostic Agent
por: Tariq, Saima, et al.
Publicado: (2020)

Quality Assessment of Tc-99m Methylene Diphosphonate (MDP) Radiopharmaceutical Prepared Using Different Cold Kit Fractionation Methods
por: Thokchom, Arun Kumar, et al.
Publicado: (2022)

Radiolabeling and Quantitative In Vivo SPECT/CT Imaging Study of Liposomes Using the Novel Iminothiolane-(99m)Tc-Tricarbonyl Complex
por: Varga, Zoltán, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v7vshfsts4vi36u5e48noe3t6g